Persistence of dominant T cell clones in accepted solid organ transplants.
نویسندگان
چکیده
Donor/recipient MHC class II matching is beneficial to the survival of allogeneic kidneys in humans and swine. In the latter, tolerance to class I-disparate grafts can be induced by a short course of immunosuppression, a peripheral mechanism that implicates regulatory T cells. Absence of treatment will lead to prompt rejection. Rejected grafts are infiltrated by dominant alloaggressive T cells, whereas there is still speculation on the specificity and function of T cells invading accepted tissues. To characterize the TCR repertoire of graft-infiltrating T cells (GITC) in accepted kidneys, we have used the RT-PCR-based spectratyping technique to assess the length polymorphism of the porcine TCRbeta chain complementary-determining region 3 (CDR3). Results show that T cells infiltrating accepted kidneys (n = 5) express a restricted polymorphism of the CDR3 length, whereas PBL from the same animal have the polymorphic distribution of CDR3 lengths found in naive animals; that the skewed Vbeta repertoire in accepted grafts involved distinct Vbeta subfamilies in otherwise MHC-identical recipient animals; that GITC clonal dominance is not caused by immunosuppression because a second kidney, accepted without drug treatment, exhibits the same TCR Vbeta CDR3 profiles than those detected in the first graft; and that intragraft clonal dominance intensifies with time, indicating progressive preeminence of nonaggressive GITC clones. Collectively, these data represent the first example, in a preclinical model, of the emergence of nonaggressive intragraft clones, which may be involved in the induction/maintenance of local tolerance to allogeneic tissues.
منابع مشابه
Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants
The goal of immunosuppression in transplantation has shifted to improving long-term outcomes, reducing drug-induced toxicities while preserving the already excellent short-term outcomes. Long-term gains in solid organ transplantation have been limited at least partly due to the nephrotoxicity and metabolic side effects of calcineurin inhibitors (CNIs). The alloimmune response requires activatio...
متن کاملUse of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants.
The goals of tolerance in patients with solid organ transplants are to eliminate the lifelong need for immunosuppressive (IS) drugs and to prevent graft loss due to rejection or drug toxicity. Tolerance with complete withdrawal of IS drugs has been achieved in recipients of HLA-matched and mismatched living donor kidney transplants in 3 medical centers using hematopoietic cell transplants to es...
متن کاملBone marrow augmentation for heart, liver, and small bowel transplantation: prolongation of graft survival and incidence of graft-versus-host disease.
THE persistence of donor leukocvtes in recipients after transplantation (chimerism) has been postulated as the basis for graft acceptance. I.: There have been direct efforts to augment chimerism in order to increase the chance of graft acceptance. even though the mechanism of the bidirectional modulation between host and chimeric cells to achieve donor-specific hyporeactivity is not clear. In t...
متن کامل-transfected Tumorigenic Clones of the Human HaCaT Cell Line ras Epidermal Morphogenesis and Keratin Expression in c-Ha-
Several tumorigenic (benign and malignant) clones have been raised from the human epidermal cell line HaCaT after transfection with the cllu-ruv oncogene (val 12) (P. Boukamp et a/.. Cancer Res., 50: 28402847, 1990). In culture, these HaCaT-nu clones expressed epidermal differentiation markers, such as keratins Kl and 10, at high density or upon depletion of retinoic acid. Accordingly, as HaCaT...
متن کاملRituximab for post-transplant lymphoproliferative disease
Post-transplant lymphoproliferative disease (PTLD) describes a heterogenous group of lymphoproliferative diseases, occurring as a result of uncontrolled B cell proliferation in the context of post-transplant immunosuppression. The incidence depends on the type of transplant and immunosuppression used; the median time to onset is shorter for recipients of stem cell transplants (2 months) than th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of immunology
دوره 167 8 شماره
صفحات -
تاریخ انتشار 2001